PHS
PFM Health Sciences Portfolio holdings
AUM
$1.15B
This Quarter Return
+20.44%
1 Year Return
+21.39%
3 Year Return
+130.75%
5 Year Return
+265.32%
10 Year Return
+1,236.5%
AUM
$3.67B
AUM Growth
+$3.67B
(+6.3%)
Cap. Flow
-$270M
Cap. Flow
% of AUM
-7.34%
Top 10 Holdings %
Top 10 Hldgs %
30.16%
Holding
125
New
27
Increased
18
Reduced
34
Closed
33
Top Buys
| 1 |
Stryker
SYK
|
$114M |
| 2 |
Puma Biotechnology
PBYI
|
$101M |
| 3 |
WCG
Wellcare Health Plans, Inc.
WCG
|
$89.8M |
| 4 |
AGN
Allergan plc
AGN
|
$84.2M |
| 5 |
Pfizer
PFE
|
$80.7M |
Top Sells
| 1 |
ONCE
Spark Therapeutics, Inc. Common Stock
ONCE
|
$224M |
| 2 |
GoDaddy
GDDY
|
$85.4M |
| 3 |
Abbott
ABT
|
$82.8M |
| 4 |
AERI
Aerie Pharmaceuticals, Inc.
AERI
|
$68.4M |
| 5 |
Blackrock
BLK
|
$65.5M |
Sector Composition
| 1 | Healthcare | 67.26% |
| 2 | Technology | 13.77% |
| 3 | Communication Services | 4.88% |
| 4 | Consumer Discretionary | 3.82% |
| 5 | Financials | 1.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ARNA
1
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $146M | 3.23% | 3,255,230 +240,558 | +8% | +$10.8M |
|
2
Zimmer Biomet
ZBH
$21B
| $121M | 2.68% | 951,246 +272,918 | +40% | +$34.9M |
|
|
3
Pfizer
PFE
$141B
| $120M | 2.66% | 2,833,096 +1,899,610 | +203% | +$80.7M |
|
|
4
Stryker
SYK
$150B
| $114M | 2.53% | +579,444 | New | +$114M |
|
5
UnitedHealth
UNH
$281B
| $112M | 2.47% | 451,689 +210,804 | +88% | +$52.1M |
|
6
Penumbra
PEN
$10.6B
| $107M | 2.36% | 727,057 -175,841 | -19% | -$25.9M |
|
|
7
Puma Biotechnology
PBYI
$254M
| $101M | 2.23% | +2,603,920 | New | +$101M |
|
8
Elevance Health
ELV
$71.8B
| $99.4M | 2.2% | 346,397 -105,024 | -23% | -$30.1M |
|
9
Humana
HUM
$36.5B
| $97M | 2.14% | 364,473 -43,620 | -11% | -$11.6M |
|
|
WCG
10
DELISTED
Wellcare Health Plans, Inc.
WCG
| $89.8M | 1.98% | +332,834 | New | +$89.8M |
|
11
ICU Medical
ICUI
$3.15B
| $89.7M | 1.98% | 374,860 +199,102 | +113% | +$47.7M |
|
12
Microchip Technology
MCHP
$35.1B
| $85.2M | 1.88% | 1,026,821 -5,671 | -0.5% | -$470K |
|
|
AGN
13
DELISTED
Allergan plc
AGN
| $84.2M | 1.86% | +574,837 | New | +$84.2M |
|
|
MYOK
14
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $83.3M | 1.84% | 1,601,307 +63,176 | +4% | +$3.28M |
|
|
15
GoDaddy
GDDY
$20.5B
| $80.8M | 1.79% | 1,074,417 -1,136,391 | -51% | -$85.4M |
|
|
BOLD
16
DELISTED
Audentes Therapeutics, Inc
BOLD
| $79.2M | 1.75% | 2,030,481 -990,778 | -33% | -$38.7M |
|
|
BPMC
17
DELISTED
Blueprint Medicines
BPMC
| $77.2M | 1.71% | 964,075 -506,361 | -34% | -$40.5M |
|
18
Thermo Fisher Scientific
TMO
$186B
| $77M | 1.7% | 281,436 +19,329 | +7% | +$5.29M |
|
19
Molina Healthcare
MOH
$9.8B
| $71.1M | 1.57% | 500,538 +151,379 | +43% | +$21.5M |
|
20
Edwards Lifesciences
EW
$47.8B
| $68.9M | 1.52% | 360,307 -180,520 | -33% | -$34.5M |
|
21
Intuit
INTU
$186B
| $66M | 1.46% | 252,539 +3,356 | +1% | +$877K |
|
22
Esperion Therapeutics
ESPR
$448M
| $65.3M | 1.44% | 1,627,079 -251,924 | -13% | -$10.1M |
|
23
Align Technology
ALGN
$10.3B
| $60.5M | 1.34% | 212,889 -24,359 | -10% | -$6.93M |
|
24
Merit Medical Systems
MMSI
$5.36B
| $60.4M | 1.34% | 977,313 +275,020 | +39% | +$17M |
|
25
New York Times
NYT
$9.74B
| $56.8M | 1.25% | 1,727,851 +918,150 | +113% | +$30.2M |
|